ANI Pharmaceuticals Announces Publication of NEW DAY Clinical Trial Results in OphthalmologyGlobeNewsWire • 04/07/26
Can ANI (ANIP) Climb 43.86% to Reach the Level Wall Street Analysts Expect?Zacks Investment Research • 04/01/26
ANI Pharmaceuticals 2026 Watchlist: Gout Sales Force and Rare DiseaseZacks Investment Research • 03/31/26
Wall Street Analysts See a 44.84% Upside in ANI (ANIP): Can the Stock Really Move This High?Zacks Investment Research • 03/12/26
ANI Pharmaceuticals, Inc. (ANIP) Presents at Barclays 28th Annual Global Healthcare Conference TranscriptSeeking Alpha • 03/11/26
ANI (ANIP) Q4 Earnings: How Key Metrics Compare to Wall Street EstimatesZacks Investment Research • 02/27/26
ANI Pharmaceuticals (ANIP) Surpasses Q4 Earnings and Revenue EstimatesZacks Investment Research • 02/27/26
ANI Pharmaceuticals Reports Record Fourth Quarter and Full Year 2025 Financial Results and Reaffirms 2026 Financial GuidanceGlobeNewsWire • 02/27/26
ANI Pharmaceuticals (ANIP) Earnings Expected to Grow: What to Know Ahead of Next Week's ReleaseZacks Investment Research • 02/20/26
ANI Pharmaceuticals to Discuss Fourth Quarter and Full Year 2025 Financial Results on February 27, 2026, at 8:00 a.m. ETGlobeNewsWire • 02/13/26